Since we have previously demonstrated that intravenous administration of IL-6 increases lung CXCL1 and MPO activity in AKI [29], we hypothesized that intratracheal administration of IL-6 to healthy mice would also increase lung CXCL1 and MPO activity. This evidence concerns the gene MPO and acute kidney injury.